Suppr超能文献

病毒和细菌感染在慢性阻塞性肺疾病急性加重中的重要性。

Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations.

作者信息

De Serres Gaston, Lampron Noël, La Forge Jacques, Rouleau Isabelle, Bourbeau Jean, Weiss Karl, Barret Béatrice, Boivin Guy

机构信息

Institut national de santé publique du Québec, Québec (Québec), Canada.

出版信息

J Clin Virol. 2009 Oct;46(2):129-33. doi: 10.1016/j.jcv.2009.07.010. Epub 2009 Aug 7.

Abstract

BACKGROUND

Few studies have evaluated the contribution of both viruses and bacteria in acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

OBJECTIVES

This study estimated the burden of both types of pathogens among adults seeking care for an AECOPD during two consecutive winter seasons.

STUDY DESIGN

Patients 50 years or older who consulted within 10 days of AECOPD onset were eligible. Clinical data were collected on a standardized questionnaire, and nasopharyngeal aspirates (NPA), paired sera, and non-induced sputum were collected. Polymerase chain reaction (PRC) assays were used to identify viral, atypical and bacterial pathogens in NPA specimen.

RESULTS

Overall, 108 patients with AECOPD were included, 88% of patients were admitted and 2 patients (2%) received intensive care. A third of patients (31%) had evidence of a viral infection, 9% with influenza A, 7% RSV and 7% with PIV-3. One patient was positive for Mycoplasma pneumoniae. Bacterial pathogens were identified in 49% of patients with available sputum, most frequently Staphylococcus aureus, Pseudomonas aeruginosa, and Haemophilus influenzae. Among virus-infected patients, 14 (58%) also had bacteria in their sputum, but co-infected patients did not present with different symptoms than patients with single infections.

CONCLUSIONS

These results suggest that influenza and RSV are frequent contributors of AECOPD, and that coinfection with bacteria does not appear to be more severe among virus-infected patients. Clinicians should be aware that AECOPD may be frequently triggered by viruses, and may consider antivirals and proper infection control measures in appropriate epidemiological setting.

摘要

背景

很少有研究评估病毒和细菌在慢性阻塞性肺疾病急性加重(AECOPD)中的作用。

目的

本研究评估了连续两个冬季因AECOPD就诊的成年人中这两种病原体的负担。

研究设计

年龄在50岁及以上且在AECOPD发病后10天内就诊的患者符合条件。通过标准化问卷收集临床数据,并采集鼻咽抽吸物(NPA)、配对血清和非诱导痰。采用聚合酶链反应(PRC)检测法鉴定NPA标本中的病毒、非典型病原体和细菌病原体。

结果

总共纳入了108例AECOPD患者,88%的患者入院,2例(2%)接受重症监护。三分之一的患者(31%)有病毒感染证据,9%感染甲型流感病毒,7%感染呼吸道合胞病毒(RSV),7%感染副流感病毒3型(PIV-3)。1例患者肺炎支原体呈阳性。在有痰标本的患者中,49%鉴定出细菌病原体,最常见的是金黄色葡萄球菌、铜绿假单胞菌和流感嗜血杆菌。在病毒感染患者中,14例(58%)痰中也有细菌,但合并感染患者与单一感染患者的症状并无不同。

结论

这些结果表明,流感和RSV是AECOPD的常见病因,病毒感染患者合并细菌感染似乎并不更严重。临床医生应意识到AECOPD可能经常由病毒引发,并在适当的流行病学环境中考虑使用抗病毒药物和采取适当的感染控制措施。

相似文献

1
Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations.
J Clin Virol. 2009 Oct;46(2):129-33. doi: 10.1016/j.jcv.2009.07.010. Epub 2009 Aug 7.
4
Time-course of upper respiratory tract viral infection and COPD exacerbation.
Eur Respir J. 2019 Oct 10;54(4). doi: 10.1183/13993003.00407-2019. Print 2019 Oct.
9
Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples.
Int J Chron Obstruct Pulmon Dis. 2019 Jan 23;14:311-319. doi: 10.2147/COPD.S188186. eCollection 2019.

引用本文的文献

1
Sensing molecular carbon dioxide: a translational focus for respiratory disease.
Physiol Rev. 2025 Oct 1;105(4):2657-2691. doi: 10.1152/physrev.00022.2024. Epub 2025 Jul 16.
7
Hypercapnia increases ACE2 expression and pseudo-SARS-CoV-2 entry in bronchial epithelial cells by augmenting cellular cholesterol.
Front Immunol. 2023 Oct 12;14:1251120. doi: 10.3389/fimmu.2023.1251120. eCollection 2023.
8
Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data.
Infect Dis Ther. 2023 Jun;12(6):1487-1504. doi: 10.1007/s40121-023-00802-4. Epub 2023 May 23.

本文引用的文献

1
Viral infections in patients with chronic obstructive pulmonary disease.
Curr Opin Pulm Med. 2008 Mar;14(2):89-94. doi: 10.1097/MCP.0b013e3282f4a99f.
2
Diagnosis of pathogens in exacerbations of chronic obstructive pulmonary disease.
Proc Am Thorac Soc. 2007 Dec;4(8):642-6. doi: 10.1513/pats.200707-101TH.
3
Respiratory syncytial virus infection in adults.
Semin Respir Crit Care Med. 2007 Apr;28(2):171-81. doi: 10.1055/s-2007-976489.
4
Role of viral infections in asthma and chronic obstructive pulmonary disease.
Am J Respir Cell Mol Biol. 2006 Nov;35(5):513-8. doi: 10.1165/rcmb.2006-0199TR. Epub 2006 Jun 15.
5
Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2006 Apr 15;173(8):871-6. doi: 10.1164/rccm.200509-1489OC. Epub 2006 Feb 2.
7
Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2006 Mar 15;173(6):639-43. doi: 10.1164/rccm.200510-1681OC. Epub 2005 Dec 30.
9
Respiratory syncytial virus infection in elderly and high-risk adults.
N Engl J Med. 2005 Apr 28;352(17):1749-59. doi: 10.1056/NEJMoa043951.
10
Latency and persistence of respiratory syncytial virus despite T cell immunity.
Am J Respir Crit Care Med. 2004 Apr 1;169(7):801-5. doi: 10.1164/rccm.200308-1203OC. Epub 2004 Jan 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验